Kidney cancer risk

Preventable cases

Kidney cancer cases are preventable, UK, 2015

 

Caused by obesity

Kidney cancer cases caused by overweight and obesity, UK, 2015

 

Caused by smoking

Kidney cancer cases caused by smoking, UK, 2015

 

The estimated lifetime risk of being diagnosed with kidney cancer is 1 in 34 (3%) for males, and 1 in 61 (2%) for females born after 1960 in the UK.[1]

These figures take account of the possibility that someone can have more than one diagnosis of kidney cancer in their lifetime (‘Adjusted for Multiple Primaries’ (AMP) method).[2]

The estimated lifetime risk of being diagnosed with kidney cancer is 1 in 34 (3%) for males, and 1 in 61 (2%) for females born after 1960 in the UK.

References

  1. Lifetime risk estimates calculated by the Statistical Information Team at Cancer Research UK. Based on Office for National Statistics (ONS) 2016-based Life expectancies and population projections. Accessed December 2017, and Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016. 
  2. Sasieni PD, Shelton J, Ormiston-Smith N, et al. What is the lifetime risk of developing cancer?: The effect of adjusting for multiple primaries. Br J Cancer, 2011. 105(3): p. 460-5. 

About this data

Data is for UK, past and projected cancer incidence and mortality and all-cause mortality rates for those born in 1961, ICD-10 C64-C66,C68.

The calculations used past and projected cancer incidence and mortality and all-cause mortality rates for those born in 1961 to project risk over the lifetime of those born in 1961 (cohort method).[1] Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment.

Last reviewed:

34% of kidney cancer cases in the UK are preventable.[1]

Kidney cancer risk is associated with a number of risk factors.[2-4]

Kidney Cancer Risk Factors

  Increases risk Decreases risk
'Sufficient' or 'convincing' evidence
  • Tobacco smoking[a,b]
  • X-radiation, gamma-radiation[a]
  • Trichloroethylene[a]
  • Plants containing aristolochic acid[b]
  • Phenacetin[b]
  • Analgesics containing phenacetin[b]
  • Body fatness[a]
 
'Limited' or 'Probable' evidence
  • Arsenic and inorganic arsenic compounds[a]
  • Cadmium and cadmium compounds[a]
  • Perfluorooctanoic acid[a]
  • Printing processes[a]
  • Welding fumes [a]
  • Aristolochic acid (not in plants)[b]
  • Adult attained height[a]
  • Alcoholic drinks[a]

International Agency for Research on Cancer (IARC) and World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) classifications.

a Kidney; b Renal pelvis and ureter.

See also

Want to generate bespoke preventable cancers stats statements? Download our interactive statement generator.

Find out more about the definitions and evidence for this data

Learn how attributable risk is calculated

References

  1. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018.
  2. International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122.  Accessed October 2018.
  3. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8.
  4. World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project Findings & Reports. Accessed October 2016.
Last reviewed:

International Agency for Research on Cancer (IARC) and World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) classify the role of this risk factor in cancer development.[1,2] 24% of kidney cancer cases in the UK are caused by overweight and obesity.[3]

Adult BMI

Adult BMI
Kidney cancer risk is 24% higher in men per 5-unit body mass index (BMI) increase, an umbrella study of meta-analyses showed.[4] Kidney cancer risk is 33% higher in women per 5-unit body mass index (BMI) increase, an umbrella study of meta-analyses showed.[4]

Overweight and obesity may increase kidney cancer risk by raising insulin, oestrogens and growth factors levels, and changing cholesterol metabolism or the immune system.[5]

Birth weight

Wilms tumour risk is higher in children with a higher birth-weight, a meta-analysis showed.[6]

UK portrait version shown here. Country versions, cancers caused by other risk factors, and landscape formats are available for free from our cancer risk publications.

Last reviewed:

International Agency for Research on Cancer (IARC) classifies the role of this risk factor in cancer development.[1] 13% of kidney cancer cases in the UK are caused by smoking.[2]

Kidney cancer risk is 33% higher in current smokers compared with non-smokers, a meta-analysis showed.[3]

Kidney cancer risk increases with the number of cigarettes smoked per day and smoking duration, a meta-analysis showed.[4] Kidney cancer risk is 50-76% higher in heavy smokers (those who smoke more than 20 cigarettes per day or have more than 50 pack-years Open a glossary item of exposure), compared with never-smokers, a meta-analysis showed.[4]

Kidney cancer risk among ex-smokers who quit more than 10 years ago is comparable to that of never-smokers, a meta-analysis showed.[4]

UK portrait version shown here. Country versions, cancers caused by other risk factors, and landscape formats are available for free from our cancer risk publications.

Last reviewed:

Kidney disease

Kidney and bladder cancer risk is 2.3 times higher in people with end stage renal disease receiving dialysis, a meta-analysis showed.[1]

Kidney stones

Kidney cancer risk among men is 41% higher in those with kidney stones, a meta-analysis showed.[2] Kidney cancer risk among women is not associated with kidney stones, a meta-analysis showed.[2]

Hypertension

Kidney cancer risk is 67% higher in people with a history of hypertension, a meta-analysis showed.[3] For every 10-mmHg increase in the systolic and diastolic blood pressure, there is a 10% and 22% increase in the risk of kidney cancer, respectively, the size of the association may differ between men and women.[3]
Kidney cancer risk is 54-100% higher in diuretics users versus non-users, a meta-analysis showed; this may relate to the underlying hypertension but evidence is unclear.[4]

Diabetes

Kidney cancer risk is 37% higher in people with type 1 diabetes compared with people without type 1 diabetes, a meta-analysis has shown.[5]

Kidney cancer risk among diabetics may be higher in insulin users than non-users, a meta-analysis showed.[6] Kidney cancer risk among diabetics is not associated with metformin or pioglitazone use,[7] meta-analyses have shown.

Non-steroidal anti-inflammatory drugs (NSAIDs)

Kidney cancer risk is 38% higher in non-aspirin NSAID ever-users, compared with never/rare users, a meta-analysis showed.[8] Kidney cancer risk is not associated with aspirin use, a meta-analysis showed.[8]

Paracetamol

Kidney cancer risk is 32% higher in paracetamol (acetaminophen) ever-users, compared with never/rare users, a meta-analysis showed.[8]

References

  1. Wong G, Staplin N, Emberson J, et al. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer 2016;16(1).
  2. Cheungpasitporn W, Thongprayoon C, O'Corragain OA, et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM 2014. pii: hcu195.
  3. Hidayat K, Du X, Zou S, et al. Blood pressure and kidney cancer risk. Journal of Hypertension 2017;35(7):1333-1344.
  4. Grossman E, Messerli FH, Goldbourt U. Antihypertensive therapy and the risk of malignancies. Eur Heart J 2001;22:1343-52.
  5. Sona M, Myung S, Park K, et al. Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies. Japanese Journal of Clinical Oncology 2018;48(5):426-433.
  6. Karlstad O, Linde JS, Vestergaard P, et al. Use of Insulin and Insulin Analogs and Risk of Cancer- Systematic Review and Meta-Analysis of Observational Studies. Curr Drug Saf. 2013 Nov 7.
  7. Colmers IN, Bowker SL, Johnson JA. Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab 2012;38(6):475-84.
  8. Choueiri TK, Je Y, Cho E. Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies. Int J Cancer 2014;134(2):384-96.
Last reviewed:

An estimated 2-4% of kidney cancers are caused by inherited factors.[1]

Renal cell carcinoma risk is 2.2-2.6 times higher in people with a first-degree relative with kidney cancer, a meta-analysis showed.[2] Renal cell carcinoma risk does not differ significantly between people whose sibling is affected and people whose parent is affected, a cohort study showed.[3]

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

The University of Manchester are currently conducting a survey into healthcare professionals' and public attitudes towards sun exposure and vitamin D.

Take part

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.